X4 Pharmaceuticals (XFOR) Other Accumulated Expenses (2017 - 2019)

X4 Pharmaceuticals (XFOR) has reported Other Accumulated Expenses for 3 consecutive years, with $280000.0 the latest figure, recorded in Q2 2019.

• For the quarter ending Q2 2019, Other Accumulated Expenses fell 36.65% year-over-year to $280000.0; the trailing twelve-month figure through Jun 2019 stood at $280000.0 (down 36.65% YoY), and the FY2018 full-year result was $249000.0, down 50.0% from the prior year.
• Other Accumulated Expenses improved to $280000.0 in Q2 2019 per XFOR's latest filing, from $271000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $498000.0 in Q4 2017 and bottomed at $249000.0 in Q4 2018.
• Historically, Other Accumulated Expenses has averaged $361857.1 across 3 years, with a median of $386000.0 in 2018.
• The sharpest annual moves came in 2018 and 2019: Other Accumulated Expenses slumped 50.0% in 2018, then sank 33.42% in 2019.
• Over 3 years, Other Accumulated Expenses stood at $498000.0 in 2017, then plunged by 50.0% to $249000.0 in 2018, then gained by 12.45% to $280000.0 in 2019.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $280000.0, $271000.0, and $249000.0 for Q2 2019, Q1 2019, and Q4 2018 respectively.